Abcam plc

Abcam PLC is a life sciences company that specializes in the production and distribution of research-grade antibodies and other research tools. The company was founded in 1998 and is headquartered in Cambridge, UK. Abcam offers a wide range of products, including primary and secondary antibodies, proteins, peptides, kits, and assays. Its products are used in research applications such as cancer research, neuroscience, stem cell research, and drug discovery. Abcam operates globally, with offices in the UK, US, China, Japan, and Australia. The company is listed on the London Stock Exchange and has a market capitalization of approximately £3.5 billion as of 2021.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.